Skip to main content
Fig. 2 | Renal Replacement Therapy

Fig. 2

From: Efficacy and safety of plasma hemodiafiltration (PHDF) in pediatric patients with multiple organ dysfunction syndrome with shock and DIC: a preliminary study

Fig. 2

Changes in IL-6 and coagulation-fibrinolysis markers (cases 5, 7, 8, 9). a IL-6, b PIC, c TAT, d PAI-1. The coagulation fibrinolytic markers showed similar trends in all four cases, but only case 7 showed an upward trend in IL-6 level. The patient in case 7 died early, and the patients in cases 5, 8, and 9 survived. IL-6, interleukin-6; TAT, thrombin–antithrombin complex; PIC, plasmin α2–plasmin inhibitor complex; PAI-1, plasminogen activator inhibitor-1. Solid line, case 7; dashed line, cases 5, 8, and 9

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us